Blog - Page 2 of 104

May 8, 2024

Dr. Alan Nelson presented on the topic: “How AI and IP Are Making a Difference in Early Cancer Detection” in a podcast sponsored by the Center for Intellectual Property Understanding (CIPU)
More Information
News
March 24, 2024

IPAS Keynote speaker, VisionGate CEO Dr. Alan Nelson, at Northwestern Kellogg School of Management and Center for IP Understanding, Intellectual Property Awareness Summit 2024: AI-Driven Early Cancer Detection: Opportunities and Challenges
More Information
News
January 30, 2024

#11,885,732:
MORPHOMETRIC GENOTYPING OF CELLS IN LIQUID BIOPSY USING OPTICAL TOMOGRAPHY
More Information
Patents
November 12, 2023

VisionGate appoints Neil Bush to its Board of Directors
More Information
News
November 12, 2023

Dr. Ankit Bharat of the Northwestern University Feinberg School of Medicine to join VisionGate’s Medical Advisory Board
More Information
News
September 9, 2023

VisionGate Presents at the World Conference on Lung Cancer for 2023 in Singapore: PneuVision® Sputum Test for Lung Cancer Achieves High Sensitivity in Detecting Both Squamous Cell Carcinoma and Adenocarcinoma
More Information
Publications
September 9, 2023

VisionGate Presents at the World Conference on Lung Cancer for 2023 in Singapore: PneuVision® Sputum Test for Lung Cancer Detects True Abnormal Cells in Non-cancer Patients with Near 100% Specificity
More Information
Publications
January 16, 2023

IRB approves a new clinical study between Northwestern University Feinberg School of Medicine and VisionGate
More Information
News
January 10, 2023

#11,551,043:
MORPHOMETRIC DETECTION OF MALIGNANCY ASSOCIATED CHANGE
More Information
Patents
January 3, 2023

#11,545,237:
MORPHOMETRIC GENOTYPING OF CELLS IN LIQUID BIOPSY USING OPTICAL TOMOGRAPHY
More Information
Patents

Previous 123 Next